MedPath

PROMOTE: A prospective randomised trial comparing embryo development

Not Applicable
Completed
Conditions
Topic: Reproductive health and childbirth
Subtopic: Reproductive Health and Childb (all Subtopics)
Disease: Reproductive Health & Childbirth
Pregnancy and Childbirth
Registration Number
ISRCTN73037149
Lead Sponsor
Southampton University Hospitals NHS Trust
Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36287638/ (added 27/10/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
120
Inclusion Criteria

1. Standard indication for IVF/ICSI treatment
2. Good understanding of written and spoken English
3. Female age under 42
4. Antral Follicle Count (AFC) of more than 15 or Anti Mullerian Hormone (AMH) of more than 10pmol/l

Exclusion Criteria

1. Any medical contraindication to IVF/ICSI
2. Previous diagnosis of HIV, Hep B or Hep C
3. High risk of Ovarian Hyperstimulation Syndrome (OHSS) as assessed prior to triggering of final oocyte maturation
4. Less than 6 2PN zygotes or more than 14 2PN zygotes available for culture

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of embryos reaching blastocyst stage in Embryoscope versus MINC benchtop incubator on day 5 after culture in the Embryoscope
Secondary Outcome Measures
NameTimeMethod
<br> 1. A comparison of the mean morphology score of embryos from each cohort on day 5 after culture in the Embryoscope versus the MINC incubator<br> 2. Number of embryos suitable for cryopreservation from Embryoscope versus MINC<br> 3. Number of usable” embryos from Embryoscope versus MINC<br> 4. Implantation rate in relation to metabolic activity of embryo(s) transferred<br> 5. A comparison of the amino acid profile in the conditioned media obtained from blastocysts after culture in the Embryoscope versus the MINC Incubator<br> 6. Correlation between metabolic activity and embryo viability as assessed by morphological and morphokinetic assessment<br>
© Copyright 2025. All Rights Reserved by MedPath